Clinical Trial Update: Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial of interferon-beta1a (AVONEX) for ulcerative colitis completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• AVONEX (Interferon beta-1a) (Interferon beta-1a)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2010-08-31